Telomerase-specific oncolytic virotherapy for human hepatocellular carcinoma

doi:10.3748/wjg.14.1274

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 8

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2955)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series.

Item

Count

PDF

294

HTML

2438

Figures (1-5)

223

Sum=2955

Feb 28, 2008 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Feb 28, 2008; 14(8): 1274-1279
Published online Feb 28, 2008. doi: 10.3748/wjg.14.1274

Full Size Figure Download Figure

Figure 1 CNHK300 hTERT mRNA expression in various cell lines. Telomerase hTERT mRNA expression was positive in cancer cell lines HepGII (A) and Hep3B (C), but not in the normal fibroblast cell line BJ (B) CNHK300 hTERT mRNA expression was detected in E1 transformed human embryonal kidney cell line HEK293 (D) as a positve control. E: Negative control, F: DNA marker.

Citation: Li YM, Song ST, Jiang ZF, Zhang Q, Su CQ, Liao GQ, Qu YM, Xie GQ, Li MY, Ge FJ, Qian QJ. Telomerase-specific oncolytic virotherapy for human hepatocellular carcinoma. World J Gastroenterol 2008; 14(8): 1274-1279
URL: https://www.wjgnet.com/1007-9327/full/v14/i8/1274.htm
DOI: https://dx.doi.org/10.3748/wjg.14.1274